References
- Khaw PT, Shah P, Elkington AR. ABC of eyes. 4th edition. Spain: BMJ Books; 2004.
- Cook CD. Glaucoma in Africa. Size of the problem and possible solutions. J Glaucoma 2009; 18(2): 124–8.
- Rotchford AP, Johnson GJ. Glaucoma in Zulus—a population-based cross-sectional survey in a rural district in South Africa. Arch Ophthalmol 2002; 120: 471–8.
- Rotchford AP, Kirwan JF, Muller MA, Johnson GJ, Roux P. Temba glaucoma study—a population-based cross-sectional survey in urban South Africa. Ophthalmology 2003; 110(2): 376–82.
- Cook CD, Knight SE, Crofton-Briggs I. Prevalence and causes of low vision and blindness in northern KwaZulu. S Afr Med J 1993; 78: 275–9.
- Ramulu P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol 2009; 20(2): 92–8.
- Spaeth G, Walt, Keener J. Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol 2006; 141(1 Suppl): S3–14.
- Nelson P, Aspinall P, Papasouliotis O, Worton B, O Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma 2003; 12(2): 139–50.
- European Glaucoma Society (EGS). 2003. Terminology and guidelines for glaucoma. Available from www.eugs.org (Accessed 27-02-2010).
- South African Glaucoma Society. 2009. Glaucoma algorithm and guidelines for glaucoma. Available from www.sags.com (Accessed 27-02-2010).
- Ntim-Amponsah CT, Amoaku WM, Ewusi RK, Idirisuriya-Khair R, Nyatepe-Coo E, Ofosu-Amaah S. Evaluation of risk factors for advanced glaucoma in Ghanaian patients. Eye 2005; 19: 528–34.
- Rhee DJ. Glaucoma: colour atlas & synopsis of clinical ophthalmology—Wills Eye Hospital. 1st edition. McGraw-Hill: USA; 2003, p. 103–17, 210–5, 230–71.
- Kanski JJ. 2007. Clinical ophthalmology: a systemic approach. 6th edition. China: Butterworth Heinemann.
- Flammer J, 2006. Glaucoma: a guide to patients. 3rd edition. Hogrefe.
- Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trail. Arc Ophthalmol 2003; 121: 48–56.
- Salmon JF, Mermoud A, Ivey A, Swanevelder SA, Hoffman M. The prevalence of primary angle closure and open angle glaucoma in Mamre, Western Cape, South Africa. Arch Ophthalmol 1993; 111: 1263–9.
- Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study. a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of POAG. Arch Ophthalmol 2002; 120: 701–3.
- The effectiveness of intraocular pressure reduction in the treatment of normal tension glaucoma. Collaborative Normal Tension Glaucoma Study Group (No authors listed). Am J Ophthalmol 1998; 126: 498–505.
- Tsai JC, Tello C, Ritch R. Angle closure glaucoma update. Focal Points- Clinical Modules for Ophthalmologists 2009; volume 27 issue 6 module 3 of 3:1–14.
- Stulting AA. Pharmacotherapy in ophthalmology. CME 1994: 189–204.
- Salmon J.F. CME/VMO Glaucoma for the GP. 1994; 179–87.
- Booysen D.J. South African Guide to Topical Ophthalmic Drugs. 2011: 72–82